The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Open accessAbstract
Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for STS provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intra-abdominal/retroperitoneal STS, gastrointestinal stromal tumors, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis, staging, and treatment of STS of the extremities, superficial trunk, or head and neck; outlines treatment recommendations by disease stage; and reviews the evidence to support the guidelines recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020461 · Cited by 4,389
Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., McArthur, G., Judson, I. R., Heinrich, M. C., Morgan, J. A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69446-4 · Cited by 2,607
Self-citationvan der Graaf, W. T., Blay, J.-Y., Chawla, S. P., Kim, D.-W., Bui-Nguyen, B., Casali, P. G., Schöffski, P., Aglietta, M., Staddon, A. P., Beppu, Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60651-5 · Cited by 2,102
O'Sullivan, B., Davis, A. M., Turcotte, R., Bell, R., Catton, C., Chabot, P., Wunder, J., Kandel, R., Goddard, K., Sadura, A., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09292-9 · Cited by 1,598
Yang, J. C., Chang, A. E., Baker, A. R., Sindelar, W. F., Danforth, D. N., Topalian, S. L., DeLaney, T., Glatstein, E., Steinberg, S. M., Merino, M. J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.197 · Cited by 1,541
Ceritinib in ALK -Rearranged Non–Small-Cell Lung Cancer
Shaw, A. T., Kim, D.-W., Mehra, R., Tan, D. S. W., Felip, E., Chow, L. Q. M., Camidge, D. R., Vansteenkiste, J., Sharma, S., De Pas, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311107 · Cited by 1,495
Demetri, G. D., Reichardt, P., Kang, Y.-K., Blay, J.-Y., Rutkowski, P., Gelderblom, H., Hohenberger, P., Leahy, M., von Mehren, M., Joensuu, H., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61857-1 · Cited by 1,406
Self-citationSirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
Bissler, J. J., McCormack, F. X., Young, L. R., Elwing, J. M., Chuck, G., Leonard, J. M., Schmithorst, V. J., Laor, T., Brody, A. S., Bean, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa063564 · Cited by 1,253
Pisters, P. W., Leung, D. H., Woodruff, J., Shi, W., & Brennan, M. F. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1679 · Cited by 1,220
Judson, I., Verweij, J., Gelderblom, H., Hartmann, J. T., Schöffski, P., Blay, J.-Y., Kerst, J. M., Sufliarsky, J., Whelan, J., Hohenberger, P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70063-4 · Cited by 1,183
Efficacy and safety of sirolimus in lymphangioleiomyomatosis
McCormack, F. X., Inoue, Y., Moss, J., Singer, L. G., Strange, C., Nakata, K., Barker, A. F., Chapman, J. T., Brantly, M. L., Stocks, J. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100391 · Cited by 1,099
Pisters, P. W., Harrison, L. B., Leung, D. H., Woodruff, J. M., Casper, E. S., & Brennan, M. F. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.859 · Cited by 1,001
Pervaiz, N., Colterjohn, N., Farrokhyar, F., Tozer, R., Figueredo, A., & Ghert, M. (2008) · Cancer · doi:10.1002/cncr.23592 · Cited by 987
Demetri, G. D., von Mehren, M., Jones, R. L., Hensley, M. L., Schuetze, S. M., Staddon, A., Milhem, M., Elias, A., Ganjoo, K., Tawbi, H., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.4734 · Cited by 841
Self-citationMaki, R. G., Wathen, J. K., Patel, S. R., Priebat, D. A., Okuno, S. H., Samuels, B., Fanucchi, M., Harmon, D. C., Schuetze, S. M., Reinke, D., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4117 · Cited by 742
Self-citationAJCC Cancer Staging Manual, 6th edition
Schmoll, H.-J. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg077 · Cited by 729
Frustaci, S., Gherlinzoni, F., De Paoli, A., Bonetti, M., Azzarelli, A., Comandone, A., Olmi, P., Buonadonna, A., Pignatti, G., Barbieri, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1238 · Cited by 712
DAVIS, A., OSULLIVAN, B., TURCOTTE, R., BELL, R., CATTON, C., CHABOT, P., WUNDER, J., HAMMOND, A., BENK, V, & KANDEL, R. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2004.12.020 · Cited by 710
Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study
Penel, N., Bui, B. N., Bay, J.-O., Cupissol, D., Ray-Coquard, I., Piperno-Neumann, S., Kerbrat, P., Fournier, C., Taieb, S., Jimenez, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.3146 · Cited by 687
Gemcitabine and Docetaxel in Patients With Unresectable Leiomyosarcoma: Results of a Phase II Trial
Hensley, M. L., Maki, R., Venkatraman, E., Geller, G., Lovegren, M., Aghajanian, C., Sabbatini, P., Tong, W., Barakat, R., & Spriggs, D. R. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.050 · Cited by 683
Tap, W. D., Jones, R. L., Van Tine, B. A., Chmielowski, B., Elias, A. D., Adkins, D., Agulnik, M., Cooney, M. M., Livingston, M. B., Pennock, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30587-6 · Cited by 584
Self-citationPhase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
Maki, R. G., D'Adamo, D. R., Keohan, M. L., Saulle, M., Schuetze, S. M., Undevia, S. D., Livingston, M. B., Cooney, M. M., Hensley, M. L., Mita, M. M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.4495 · Cited by 569
Self-citationEdmonson, J. H., Ryan, L. M., Blum, R. H., Brooks, J. S., Shiraki, M., Frytak, S., & Parkinson, D. R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.7.1269 · Cited by 516
Gronchi, A., Ferrari, S., Quagliuolo, V., Broto, J. M., Pousa, A. L., Grignani, G., Basso, U., Blay, J.-Y., Tendero, O., Beveridge, R. D., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30334-0 · Cited by 496
Wagner, A. J., Malinowska-Kolodziej, I., Morgan, J. A., Qin, W., Fletcher, C. D. M., Vena, N., Ligon, A. H., Antonescu, C. R., Ramaiya, N. H., Demetri, G. D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.2981 · Cited by 399
Agulnik, M., Yarber, J. L., Okuno, S. H., von Mehren, M., Jovanovic, B. D., Brockstein, B. E., Evens, A. M., & Benjamin, R. S. (2013) · Annals of Oncology · doi:10.1093/annonc/mds237 · Cited by 389
Self-citationArndt, C. A. S., Stoner, J. A., Hawkins, D. S., Rodeberg, D. A., Hayes-Jordan, A. A., Paidas, C. N., Parham, D. M., Teot, L. A., Wharam, M. D., Breneman, J. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3768 · Cited by 380
A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma
Gortzak, E., Azzarelli, A., Buesa, J., Bramwell, V. H. C., van Coevorden, F., van Geel, A. N., Ezzat, A., Santoro, A., Oosterhuis, J. W., van Glabbeke, M., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00083-1 · Cited by 379
High‐dose tamoxifen and sulindac as first‐line treatment for desmoid tumors
Hansmann, A., Adolph, C., Vogel, T., Unger, A., & Moeslein, G. (2004) · Cancer · doi:10.1002/cncr.11937 · Cited by 357
George, S., Merriam, P., Maki, R. G., Van den Abbeele, A. D., Yap, J. T., Akhurst, T., Harmon, D. C., Bhuchar, G., O'Mara, M. M., D'Adamo, D. R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.9890 · Cited by 321
Self-citationSaylors, R. L., Stine, K. C., Sullivan, J., Kepner, J. L., Wall, D. A., Bernstein, M. L., Harris, M. B., Hayashi, R., & Vietti for the Pediatric Oncology Group, T. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3463 · Cited by 315
Davies, D. M., de Vries, P. J., Johnson, S. R., McCartney, D. L., Cox, J. A., Serra, A. L., Watson, P. C., Howe, C. J., Doyle, T., Pointon, K., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0445 · Cited by 309
García-del-Muro, X., López-Pousa, A., Maurel, J., Martín, J., Martínez-Trufero, J., Casado, A., Gómez-España, A., Fra, J., Cruz, J., Poveda, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.6107 · Cited by 307
ELIAS, A. D., RYAN, L. M., Sulkes, A., Collins, J. M., Aisner, J., & Antman, K. H. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.9.1208 · Cited by 275
Cassier, P. A., Gelderblom, H., Stacchiotti, S., Thomas, D., Maki, R. G., Kroep, J. R., van der Graaf, W. T., Italiano, A., Seddon, B., Dômont, J., et al. (2012) · Cancer · doi:10.1002/cncr.26409 · Cited by 265
Park, M. S., Patel, S. R., Ludwig, J. A., Trent, J. C., Conrad, C. A., Lazar, A. J., Wang, W., Boonsirikamchai, P., Choi, H., Wang, X., et al. (2011) · Cancer · doi:10.1002/cncr.26098 · Cited by 261
Self-citationRadiation-Associated Sarcoma of Bone and Soft Tissue
Brady, M. S. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420120013002 · Cited by 258
Folpe, A. L., Lyles, R. H., Sprouse, J. T., Conrad, E. U., & Eary, J. F. (2000) · PubMed · Cited by 257
Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
Gounder, M. M., Lefkowitz, R. A., Keohan, M. L., D'Adamo, D. R., Hameed, M., Antonescu, C. R., Singer, S., Stout, K., Ahn, L., & Maki, R. G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3322 · Cited by 255
O'Sullivan, B., Griffin, A. M., Dickie, C. I., Sharpe, M. B., Chung, P. W. M., Catton, C. N., Ferguson, P. C., Wunder, J. S., Deheshi, B. M., White, L. M., et al. (2013) · Cancer · doi:10.1002/cncr.27951 · Cited by 248
Bramwell, V, Rouesse, J., Steward, W., Santoro, A., Schraffordt-Koops, H., Buesa, J., Ruka, W., Priario, J., Wagener, T., & Burgers, M. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.6.1137 · Cited by 244
Schöffski, P., Ray-Coquard, I. L., Cioffi, A., Bui, N. B., Bauer, S., Hartmann, J. T., Krarup-Hansen, A., Grünwald, V., Sciot, R., Dumez, H., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70230-3 · Cited by 244
Beane, J. D., Yang, J. C., White, D., Steinberg, S. M., Rosenberg, S. A., & Rudloff, U. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3732-4 · Cited by 243
Penel, N., Le Cesne, A., Bui, B. N., Perol, D., Brain, E. G., Ray-Coquard, I., Guillemet, C., Chevreau, C., Cupissol, D., Chabaud, S., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq341 · Cited by 235
Schlemmer, M., Reichardt, P., Verweij, J., Hartmann, J. T., Judson, I., Thyss, A., Hogendoorn, P. C. W., Marreaud, S., Glabbeke, M. V., & Blay, J. Y. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.037 · Cited by 233
Beverly Raney, R., Walterhouse, D. O., Meza, J. L., Andrassy, R. J., Breneman, J. C., Crist, W. M., Maurer, H. M., Meyer, W. H., Parham, D. M., & Anderson, J. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.4469 · Cited by 230
Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma
Grobmyer, S. R., Maki, R. G., Demetri, G. D., Mazumdar, M., Riedel, E., Brennan, M. F., & Singer, S. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh431 · Cited by 224
Baldini, E. H., Goldberg, J., Jenner, C., Manola, J. B., Demetri, G. D., Fletcher, C. D. M., & Singer, S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3252 · Cited by 222
Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor)
de Camargo, V. P., Keohan, M. L., D'Adamo, D. R., Antonescu, C. R., Brennan, M. F., Singer, S., Ahn, L. S., & Maki, R. G. (2010) · Cancer · doi:10.1002/cncr.25089 · Cited by 218
Kawai, A., Araki, N., Sugiura, H., Ueda, T., Yonemoto, T., Takahashi, M., Morioka, H., Hiraga, H., Hiruma, T., Kunisada, T., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70098-7 · Cited by 217
Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis
Eary, J. F., O'Sullivan, F., Powitan, Y., Chandhury, K., Vernon, C., Bruckner, J. D., & Conrad, E. U. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0859-5 · Cited by 213
Pappo, A. S., Lyden, E., Breitfeld, P., Donaldson, S. S., Wiener, E., Parham, D., Crews, K. R., Houghton, P., & Meyer, W. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1720 · Cited by 201
Self-citationEvilevitch, V., Weber, W., Tap, W. D., Allen-Auerbach, M., Chow, K., Nelson, S. D., Eilber, F. R., Eckardt, J. J., Elashoff, R. M., Phelps, M. E., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1762 · Cited by 199
Self-citationBenz, M. R., Czernin, J., Allen-Auerbach, M. S., Tap, W. D., Dry, S. M., Elashoff, D., Chow, K., Evilevitch, V., Eckardt, J. J., Phelps, M. E., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2537 · Cited by 197
Self-citationSchwarzbach, M. H. M., Dimitrakopoulou-Strauss, A., Willeke, F., Hinz, U., Strauss, L. G., Zhang, Y.-M., Mechtersheimer, G., Attigah, N., Lehnert, T., & Herfarth, C. (2000) · Annals of Surgery · doi:10.1097/00000658-200003000-00011 · Cited by 189
Sunitinib malate in solitary fibrous tumor (SFT)
Stacchiotti, S., Negri, T., Libertini, M., Palassini, E., Marrari, A., Troia, B. D., Gronchi, A., Tos, A. P. D., Morosi, C., Messina, A., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds143 · Cited by 173
Montemurro, M., Schöffski, P., Reichardt, P., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.030 · Cited by 149
Pulmonary Resection of Metastatic Sarcoma: Prognostic Factors Associated With Improved Outcomes
Kim, S., Ott, H. C., Wright, C. D., Wain, J. C., Morse, C. R., Gaissert, H. A., Donahue, D. M., Mathisen, D. J., & Lanuti, M. D. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.05.081 · Cited by 146
Albertsmeier, M., Rauch, A., Roeder, F., Hasenhütl, S. M., Pratschke, S., Kirschneck, M., Gronchi, A., Jebsen, N. L., Cassier, P. A., Sargos, P., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6081-2 · Cited by 146
Response to Sunitinib Malate in Advanced Alveolar Soft Part Sarcoma
Stacchiotti, S., Tamborini, E., Marrari, A., Brich, S., Rota, S. A., Orsenigo, M., Crippa, F., Morosi, C., Gronchi, A., Pierotti, M. A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2050 · Cited by 145
Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa
Italiano, A., Delcambre, C., Hostein, I., Cazeau, A. L., Marty, M., Avril, A., Coindre, J., & Bui, B. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq044 · Cited by 139
Multifactorial Analysis of Long-term Follow-up (More Than 5 Years) of Primary Extremity Sarcoma
Lewis, J. J. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.2.190 · Cited by 129
Park, S. H., Ryu, M., Ryoo, B., Im, S., Kwon, H.-C., Lee, S. S., Park, S. R., Kang, B. Y., & Kang, Y. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9795-9 · Cited by 117
Mascarenhas, L., Lyden, E. R., Breitfeld, P. P., Walterhouse, D. O., Donaldson, S. S., Paidas, C. N., Parham, D. M., Anderson, J. R., Meyer, W. H., & Hawkins, D. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7390 · Cited by 104
Soft-tissue sarcoma: MR imaging vs sonography for detection of local recurrence after surgery.
Choi, H., Varma, D. G. K., Fornage, B. D., Kim, E. E., & Johnston, D. A. (1991) · American Journal of Roentgenology · doi:10.2214/ajr.157.2.1853821 · Cited by 102
Self-citationPenel, N., Grosjean, J., Robin, Y. M., Vanseymortier, L., Clisant, S., & Adenis, A. (2008) · Sarcoma · doi:10.1155/2008/459386 · Cited by 96
A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma
Talbot, S. M., Keohan, M. L., Hesdorffer, M. E., Orrico, R., Bagiella, E., Troxel, A. B., & Taub, R. N. (2003) · Cancer · doi:10.1002/cncr.11730 · Cited by 95
Breitfeld, P. P., Lyden, E. R., Raney, R. B., Teot, L. A., Wharam, M. D., Lobe, T. E., Crist, W., Maurer, H. M., Donaldson, S. S., & Ruymann, F. B. (2001) · The American journal of pediatric hematology/oncology · doi:10.1097/00043426-200105000-00010 · Cited by 90
Phase 2 study of nilotinib as third‐line therapy for patients with gastrointestinal stromal tumor
Sawaki, A., Nishida, T., Doi, T., Yamada, Y., Komatsu, Y., Kanda, T., Kakeji, Y., Onozawa, Y., Yamasaki, M., & Ohtsu, A. (2011) · Cancer · doi:10.1002/cncr.26120 · Cited by 88
Gingrich, A. A., Bateni, S. B., Monjazeb, A. M., Darrow, M. A., Thorpe, S. W., Kirane, A., Bold, R. J., & Canter, R. J. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6019-8 · Cited by 85
Benson, C., Vitfell-Rasmussen, J., Maruzzo, M., et al. (2014) · PubMed · Cited by 82
Alamanda, V. K., Crosby, S. N., Archer, K. R., Song, Y., Schwartz, H. S., & Holt, G. E. (2012) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2012.08.024 · Cited by 75
Treatment of children with relapsed soft tissue sarcoma: Report of the German CESS/CWS REZ 91 Trial
Klingebiel, T., Pertl, U., Hess, C. F., Jürgens, H., Kościelniak, E., Pötter, R., Heek-Romanowski, R. V., Rossi, R., Schött, C., Spaar, H.-J., et al. (1998) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(199805)30:5<269::aid-mpo2>3.0.co;2-d · Cited by 66
Effective follow-up strategies in soft tissue sarcoma
Whooley, B. P., Mooney, M., Gibbs, J. F., & Kraybill, W. G. (1999) · Seminars in Surgical Oncology · doi:10.1002/(sici)1098-2388(199907/08)17:1<83::aid-ssu11>3.0.co;2-w · Cited by 65
Vassal, G., Couanet, D., Stockdale, E., Geoffray, A., Geoerger, B., Orbach, D. H., Pichon, F., Gentet, J. C., Picton, S. V., Bergeron, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1960 · Cited by 65
MRI surveillance following treatment of extremity soft tissue sarcoma
Cheney, M. D., Giraud, C., Goldberg, S. I., Rosenthal, D. I., Hornicek, F. J., Choy, E., Mullen, J. T., Chen, Y., & DeLaney, T. F. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23541 · Cited by 62
The Treatment and Outcome of Patients With Soft Tissue Sarcomas and Synchronous Metastases
Kane, J. M., Finley, J. W., Driscoll, D., Kraybill, W. G., & Gibbs, J. F. (2002) · Sarcoma · doi:10.1080/1357714021000022168 · Cited by 58
Self-citationKuttesch, J. F., Krailo, M., Madden, T. L., Johansen, M. J., & Bleyer, A. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22133 · Cited by 54
Predictors and clinical significance of local recurrence in extremity soft tissue sarcoma
Alamanda, V. K., Crosby, S. N., Archer, K. R., et al. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.711953 · Cited by 50
Isolated Limb Infusion for Advanced Soft Tissue Sarcoma of the Extremity
Moncrieff, M. D., Kroon, H. M., Kam, P. C. A., Stalley, P., Scolyer, R. A., & Thompson, J. F. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0045-5 · Cited by 49
Kim, B., Chen, Y.-L. E., Kirsch, D. G., Goldberg, S. I., Kobayashi, W. K., Kung, J., Wolfgang, J. A., Doppke, K. P., Rosenberg, A. E., Nielsen, G. P., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.086 · Cited by 49
Voss, R. K., Chiang, Y., Torres, K. E., Guadagnolo, B. A., Mann, G. N., Feig, B. W., Cormier, J. N., & Roland, C. L. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6015-z · Cited by 34
Pappo, A. S., Bowman, L. C., Furman, W. L., Rao, B. N., Kun, L. E., Jenkins, J. J., Crom, W. R., Luo, X., Kaste, S. C., Avery, L., et al. (1997) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199709000-00006 · Cited by 28
Self-citationClinical applications of positron emission tomography in sarcoma management
Quak, E., van de Luijtgaarden, A. C. M., de Geus‐Oei, L., van der Graaf, W. T. A., & Oyen, W. J. G. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.133 · Cited by 26
Patel, S. A., Royce, T. J., Barysauskas, C. M., Thornton, K. A., Raut, C. P., & Baldini, E. H. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5755-5 · Cited by 23
Cited by
Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development
Shen, G., Zheng, F., Ren, D., Du, F., Dong, Q., Wang, Z., Zhao, F., Ahmad, R., & Zhao, J. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0664-7 · Cited by 658
Bonvalot, S., Rutkowski, P. L., Thariat, J., Carrère, S., Ducassou, A., Sunyach, M.-P., Agoston, P., Hong, A., Mervoyer, A., Rastrelli, M., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30326-2 · Cited by 536
Guidelines for the Management of Soft Tissue Sarcomas
Grimer, R., Judson, I., Peake, D., & Seddon, B. (2010) · Sarcoma · doi:10.1155/2010/506182 · Cited by 432
Improved survival using specialized multidisciplinary board in sarcoma patients
Blay, J.-Y., Soibinet, P., Penel, N., Bompas, E., Duffaud, F., Stoeckle, E., Mir, O., Adam, J., Chevreau, C., Bonvalot, S., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx484 · Cited by 371
Yu, H. A., Sima, C. S., Huang, J., Solomon, S. B., Rimner, A., Paik, P., Pietanza, M. C., Azzoli, C. G., Rizvi, N. A., Krug, L. M., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31827e1f83 · Cited by 341
Metadata
- Authors
- von Mehren, M., Randall, R. L., Benjamin, R. S., Boles, S., Bui, M. M., Ganjoo, K. N., George, S., Gonzalez, R. J., Heslin, M. J., Kane, J. M., Keedy, V., Kim, E., Koon, H., Mayerson, J., McCarter, M., McGarry, S. V., Meyer, C., Morris, Z. S., O'Donnell, R. J., Pappo, A. S., Paz, I. B., Petersen, I. A., Pfeifer, J. D., Riedel, R. F., Ruo, B., Schuetze, S., Tap, W. D., Wayne, J. D., Bergman, M. A., & Scavone, J. L.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2018-05
- Volume
- 16
- Issue
- 5
- Pages
- 536-563
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2419095525
- Cited by
- 736
- References
- 85
- FWCI
- 63.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.